Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 16|pp. 20661–20683
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
Back to articleFigure 6(6 of 9)
100%
Figure 6
Figure 6.Six immune-related gene sets were enriched by GSEA.
Figure 6 — METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas | Aging